Literature DB >> 25801242

Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population.

Md Bayejid Hosen1, Md Abdus Salam, Md Fakhrul Islam, Ashfaque Hossain, M Zakir Hossain Hawlader, Yearul Kabir.   

Abstract

TP53 is considered to be the most frequently mutated gene in every forms of human cancer. The objective of this study was to evaluate the association of TP53 codon 72 and 248 polymorphisms with the susceptibility and severity of bladder cancer in Bangladeshi population. A case-control study on 102 bladder cancer patients and 140 control subjects was conducted. The genotype analysis was done by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) method. The patients with Pro/Pro genotypes at 72 position were at high risk (odds ratio (OR) = 3.02; 95 % confidence interval (95 % CI) = 1.42 to 6.40) of developing bladder cancer. The cigarette smokers with Pro/Pro genotypes at 72 position were found to have a 3.91-fold increased risk to develop bladder cancer (OR = 3.91; 95 % CI = 1.33 to 11.5). There was no significant association of codon 248 polymorphisms with bladder cancer in the study population. Taken together, these findings indicate an association between p53 codon72 polymorphism and bladder cancer risk in Bangladeshi population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801242     DOI: 10.1007/s13277-015-3324-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

Review 2.  Bladder cancer: epidemiology, diagnosis, and management.

Authors:  Chris Leo Pashos; Marc F Botteman; Benjamin Lewis Laskin; Alberto Redaelli
Journal:  Cancer Pract       Date:  2002 Nov-Dec

3.  P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.

Authors:  Ting Xu; Zi-Cheng Xu; Qin Zou; Bin Yu; Xin-En Huang
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

5.  N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.

Authors:  Md Bayejid Hosen; Jahidul Islam; Md Abdus Salam; Md Fakhrul Islam; M Zakir Hossain Hawlader; Yearul Kabir
Journal:  Asia Pac J Clin Oncol       Date:  2014-11-06       Impact factor: 2.601

6.  Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.

Authors:  M Siddique; K Sabapathy
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

7.  Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract.

Authors:  Mutsuo Furihata; Atsushi Kurabayashl; Manabu Matsumoto; Hiroshi Sonobe; Yuji Ohtsuki; Naotami Terao; Morimasa Kuwahara; Taro Shuin
Journal:  J Pathol       Date:  2002-05       Impact factor: 7.996

Review 8.  Gene polymorphisms in bladder cancer.

Authors:  Maria Franekova; Erika Halasova; Eva Bukovska; Jan Luptak; Dusan Dobrota
Journal:  Urol Oncol       Date:  2007-10-29       Impact factor: 3.498

9.  p53 codon 72 polymorphism as a progression index for bladder cancer.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Tsan-Jung Yu; Wen-Jen Wu; Ming-Chang Yang; For-Wey Lung
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

10.  P53 codon 11, 72, and 248 gene polymorphisms in endometriosis.

Authors:  Yao-Yuan Hsieh; Chich-Sheng Lin
Journal:  Int J Biol Sci       Date:  2006-07-12       Impact factor: 6.580

View more
  6 in total

1.  Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.

Authors:  Shiirevnyamba Avirmed; Bo-Shen Wang; Baasansuren Selenge; Amarsaikhan Sanjaajamts; Batmunkh Ganbat; Ulziisaikhan Erdenebileg; Myagmarsuren Purevsuren; Sarantsetseg Jigjidsuren; Munkhbat Batmunkh; Yi-Jang Lee
Journal:  Mol Clin Oncol       Date:  2017-07-13

2.  Association of Glutathione S-Transferase theta 1 and mu 1 Genes Polymorphisms with the Susceptibility of Myocardial Infarction in Bangladesh.

Authors:  Jyosna Khanam; Delowar Hossain; Bayejid Hosen; Mesbah Uddin; Asadul Kabir; Mohammad Anwarul Bari
Journal:  Rep Biochem Mol Biol       Date:  2020-10

Review 3.  A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.

Authors:  Golap Babu; Shad Bin Islam; Md Asaduzzaman Khan
Journal:  Mol Biol Rep       Date:  2022-03-11       Impact factor: 2.742

4.  TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study.

Authors:  Yuan Fang; Xuemei Wu; Lin Li; Jinhong Zhu; Haiyan Wu; Haixia Zhou; Jing He; Yizhen Wang
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

5.  TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.

Authors:  Lei Zhang; Yi Wang; Zhiqiang Qin; Ran Li; Rong Cong; Chengjian Ji; Xianghu Meng; Yamin Wang; Jiadong Xia; Ninghong Song
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

Review 6.  Genetic susceptibility of bladder cancer in the Lebanese population.

Authors:  Hampig Raphael Kourie; Bahaa Succar; Eliane Chouery; Cybel Mehawej; Nizar Ahmadieh; Joseph Zouein; Avedis Mardirossian; Nadine Jalkh; Ghassan Sleilaty; Joseph Kattan; Elie Nemr
Journal:  BMC Med Genomics       Date:  2022-10-17       Impact factor: 3.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.